Now showing items 1-15 of 15

    • Armijo Fernández, Daniela; Valenzuela Ahumada, Fernando; Saint-Pierre Contreras, Gustavo; Cortés González, Andrea (Elsevier, 2020)
    • de la Cruz, Claudia; de Carvhalo, André; Dorantes, Gladys; Londoño García, Angela; González, César; Maskin, Matías; Podoswa, Nancy; Redfern, Jan; Valenzuela Ahumada, Fernando; van der Walt, Joelle; Romiti, Ricardo (Wiley Blackwell, 2016)
      Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while maintaining the safety and efficacy profile of their branded innovator comparators. To understand the ...
    • González, César; Franco, Manuel; Londoño, Ángela; Valenzuela Ahumada, Fernando (Wiley, 2020)
      Some studies have demonstrated that neurotransmitters are involved in the pathogenesis of numerous skin conditions, including psoriasis, addressing the close correlation between the skin and the central nervous system. ...
    • Valenzuela Ahumada, Fernando; Cruz Fernandez, C. de la; Galimberti, R. L.; Gurbuz, S.; McKean Matthews, M.; Goncalves, L.; Romiti, R. (Elsevier, 2017)
      Background and objectives: Ixekizumab demonstrated greater efficacy than placebo and etanercept in UNCOVER-3. Subgroup analysis of Latin American patients was performed. We report 12-week and 60-week data. Patients and ...
    • Valdés Arrieta, María del Pilar; Schroeder, Francisca; Roizen G., Vicky; Honeyman Mauro, Juan; Sánchez M, Leonardo (2006)
      Background: Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF- a) antibody. This ...
    • Valenzuela, F. J.; Silva, P.; Valdés, M. P.; Papp, K. (2011)
      Background: Clinical characteristics of psoriasis vary between different races and climates. There are few data on Latin American and even fewer on Chilean patients with psoriasis. Objectives: To assess that clinical ...
    • Arellano Lorca, Javier; Yagnam, Mathias; Vidal, Martin; Corredoira Salum, Yamile (Sociedad Chilena de Infectología, 2017)
      HIV infection can be manifested with different skin symptoms, which are sometimes considered infection markers. Erythrodermic psoriasis is a possible manifestation, which is a widespread form of psoriasis. We report a ...
    • Valenzuela, Fernando; Fernandez, Javier D.; Sánchez, Margarita; Zamudio, Andrea (Soc. Brasileira Dermatología, 2018-06)
      Erythrodermic psoriasis is a rare but severe type of psoriasis that may be triggered by human immunodeficiency virus infection. We describe the case of a 65-year-old male patient with chronic psoriasis who presents an ...
    • Arellano, Javier; Yagnam, Mathias; Vidal, Martín; Corredoira, Yamile (Sociedad Chilena de Infectologia, 2017)
      © 2018, Sociedad Chilena de Infectologia. All rights reserved. HIV infection can be manifested with different skin symptoms, which are sometimes considered infection markers. Erythrodermic psoriasis is a possible manifestation, ...
    • Calderón H, Perla; Valdés A, Pilar; Zemelman Decarli, Viviana; Poniachik Teller, Jaime; Hurtado H, Carmen; Garmendia Miguel, María Luisa; Abumohor G, Patricia; Echavarri P, María Cristina (2007)
      Background: A possible relationship has been reported between psoriasis and celiac disease, with common pathogenic mechanisms that may need further investigation. Aim: To investigate the presence of clinical and serological ...
    • Valenzuela, Fernando; Fernández, Javier; Jiménez, Constanza; Cavagnola, Daniela; Mancilla, Juan Felipe; Astorga, Jessica; Hernández Ríos, Emma; Fernández, Alejandra (MDPI, 2021)
      : Psoriasis is a chronic immunoinflammatory skin disease. Although its diagnosis is clinical, differences in the appearance and severity of lesions pose a challenge for clinicians worldwide. The use of accessible biomarkers ...
    • Santa María, Pablo; Valenzuela, Fernando; Morales Huber, Claudia; Fuente Vera, Milton de la; Cullen, Roberto (Pagepress Publ, 2017)
      We report the case of a 56-year old male with severe plaque psoriasis that was successfully treated with ixekizumab, a new anti interleukin (IL)-17 monoclonal antibody. During the first months of treatment he developed a ...
    • Witker Jiménez, Constanza; Carvajal Aguilera, Daniela; Hernández, Marcela; Valenzuela Ahumada, Fernando; Astorga, Jessica; Fernández, Alejandra (Elsevier, 2021)
      Background: Psoriasis and periodontitis are immunologically mediated chronic inflammatory diseases. Epidemiologic evidence has linked both; however, the change of markers in gingival crevicular fluid has been poorly ...
    • Kleyn, C. Elise; Talbot, Peter S.; Mehta, Nehal N.; Sampogna, Francesca; Bundy, Chris; Ashcroft, Darren M.; Kimball, Alexa B.; Van De Kerkhof, Peter; Griffiths, Christopher E. M.; Valenzuela Ahumada, Fernando; Van Der Walt, Joelle M.; Aberra, Tsion; Puig, Lluís (Acta Dermato-Venereologica, 2020)
      Psoriasis is a systemic, relapsing, inflammatory disease associated with serious comorbidities including mood problems and/or unhealthy lifestyle behaviours. Cutaneous and systemic abnormalities in innate and acquired ...
    • Chouela, Edgardo; Amaya, Mario; Londoño, Angela; Romiti, Ricardo; Valenzuela, Fernando; Duarte, Artur A.; Alfonzo, Ricardo Perez; Borlenghi, Cecilia (Dermatology Online Journal, 2016)
      © 2016 by the article author(s). During the last few decades, management of psoriasis has changed worldwide, owing to a better understanding of its pathophysiology and the introduction of new treatments. As experts in the ...